TLR1/2 Activation during Heterologous Prime-Boost Vaccination (DNA-MVA) Enhances CD8+ T Cell Responses Providing Protection against Leishmania (Viannia)

Open Access

Peer-reviewed

Research Article

Asha Jayakumar,

Affiliation Yale University School of Public Health, New Haven, Connecticut, United States of America
⨯
Tiago M. Castilho,

Affiliation Yale University School of Public Health, New Haven, Connecticut, United States of America
⨯
Esther Park,

Affiliation Yale University School of Public Health, New Haven, Connecticut, United States of America
⨯
Karen Goldsmith-Pestana,

Affiliation Yale University School of Public Health, New Haven, Connecticut, United States of America
⨯
Jenefer M. Blackwell,

Affiliation Centre for Child Health Research, Telethon Institute for Child Health Research, University of Western Australia, Perth, Australia
⨯
Diane McMahon-Pratt

* E-mail: diane.mcmahon-pratt@yale.edu

Affiliation Yale University School of Public Health, New Haven, Connecticut, United States of America
⨯

Reader Comments (0)

Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Parasitic diseases
Is the Subject Area "Parasitic diseases" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Leishmania
Is the Subject Area "Leishmania" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.